Safety and Efficacy of Topical Bacteriotherapy for Atopic Dermatitis Using Staphylococcus Hominis A9

Go Back to All Clinical Trials

Safety and Efficacy of Topical Bacteriotherapy for Atopic Dermatitis Using Staphylococcus Hominis A9

Brief description of study

The study aims to investigate the safety of applying a gel containing a bacteria called S. hominis A9 to the skin on participants with atopic dermatitis. The study will also investigate if S. hominis A9 will work to treat atopic dermatitis.

Eligible participants will be asked to put a gel on their skin twice daily for 14 weeks. Half of all study participants will be asked to apply gel with S. hominis A9 bacteria mixed in, and half will be asked to apply a gel without any bacteria mixed in.

Clinical Study Identifier: s24-01949

ClinicalTrials.gov Identifier: NCT06504160

Other Investigator: Anna H Nowak-Wegrzyn.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies